Drug developer Pfizer Inc. said that its potential rheumatoid arthritis drug met key treatment goals in two late-stage studies. The drug candidate tofacitinib, formerly called tasocitinib, met its key goals of reducing signs and symptoms of the condition.
Pfizer Inc. said shareholders at its annual meeting voted in favor of its nominees to its board and for a proposed executive compensation package. Pfizer, the world's largest drugmaker, also said it is maintaining its quarterly dividend of 20 cents.
A much cheaper drug has proved just as good as a $2,000 monthly shot at treating a common eye disorder that can lead to blindness, a long-awaited study has found. It also shows that patients can be treated less often, sparing them a lot of pain and expense.
Human Genome Sciences Inc. reported a larger first-quarter loss as it booked bigger costs due to licensing an experimental cancer drug and launching its newly-approved lupus drug Benlysta.
Merck & Co. said its first-quarter profit more than tripled as strong sales of key drugs and lower costs from integrating its Schering-Plough acquisition offset sales lost to competition from generic versions of its drugs.
European Union antitrust regulators said they are investigating whether drug makers Cephalon and Teva were working to keep a generic version of sleep-disorder drug Provigil out of the European market.
A federal jury awarded $212 million to a Virginia man who claimed injections of the wrinkle-smoothing drug Botox to treat hand tremors and writer's cramp left him brain-damaged and disabled.
MOCON, Inc. is introducing the MultiCheck 400, a first-of-its-kind combination testing system for packages with one-way degassing valves. The system measures oxygen headspace, leak detection, and seal strength.
Integrated DNA Technologies offers its double-quenched probe, to increase the accuracy and reliability of 5’ nuclease qPCR experiments. This design positions an internal ZEN quencher 9 bases from the 5’ fluorophore, which increases sensitivity.
Pain Therapeutics Inc. on reported a smaller first-quarter loss on lower costs as the company awaits a regulatory decision on the painkiller Remoxy.
Danish pharmaceutical company Novo Nordisk A/S says first-quarter net profit grew 23 percent to 4.07 billion kroner on strong sales. The world's biggest insulin maker says net profit in the January-March period grew from 3.3 billion kroner a year earlier.
White blood cells trained by scientists to attack tumors tend to fade away quickly when injected into cancer patients. A new technique, however, can allow the cells to survive in patients' bloodstreams for well over a year.
Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies.
Shire plc announced positive results from a signal-finding study of Vyvanse Capsules assessing its effect in a prospective examination of adults with negative symptom predominant schizophrenia.
The first new drug to treat hepatitis C in over 20 years moved one step closer to approval when a panel of government experts endorsed Merck's boceprevir as an effective treatment for the virus.